icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
gsFB7V3v9VSpfyQu
Listen
